A2073
A2073 is a flavagline derivative that potently inhibits the proliferation of erythroleukemia cells by causing cell cycle arrest and suppressing the MAPK, NF-κB, and PI3K signaling pathways. A2073 formes stable interactions with cell cycle-related proteins (CDK1, CCNA2, PRIM1). A2073 exhibits significant anti-proliferative activity against tumor cells while maintaining a favorable toxicity profile in a zebrafish xenograft tumor model. A2073 can be used for the study of acute erythroleukemia.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 2834742-70-8
- 分子式: C33H37NO7
- 分子量:559.65
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
生物活性
A2073 (25-100 nM, 24-72 h) significantly inhibites the proliferation of HEL and K562 cells in a dose- and time-dependent manner, with IC50 values of 55.02 nM (HEL) and 77.07 nM (K562)[1].
A2073 (25-100 nM, 24-72 h) reduces HEL cell numbers without significantly increasing apoptosis, induces erythroid differentiation in HEL cells as evidenced by increased CD71 expression, and causes cell cycle arrest while downregulating key cell cycle regulatory proteins[1].
A2073 (25-100 nM, 48 h) downregulates key proteins in the MAPK (RAS, RAF, MAPK, MEK), PI3K-AKT (PI3K, AKT), and NF-κB (p-NF-κB, p-IκBα) pathways[1].
A2073 formes stable interactions with cell cycle-related proteins (CDK1, CCNA2, PRIM1)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HEL cells
-
Concentration:/
-
Incubation Time:72 h
-
Result:Reduced HEL cell numbers more effectively than Cytarabine (Ara-C) (HY-13605), with a lower IC50 (55.02 nM vs. 73.36 nM)
-
Cell Line:HEL cells
-
Concentration:100 nM
-
Incubation Time:48 h
-
Result:Increased the expression levels of erythroid differentiation markers GATA1, EKLF, SHIP1, and NFE2.
-
Cell Line:HEL cells
-
Concentration:25, 50, 100 nM
-
Incubation Time:24, 48, 72 h
-
Result:Caused cell cycle arrest in the G0 and G2 phases, reduces the proportion of cells in the S phase.
-
Cell Line:HEL cells
-
Concentration:25, 50, 100 nM
-
Incubation Time:48 h
-
Result:Downregulatesd key cell cycle regulatory proteins including CMYC, CDK1, CDK2, CCNB1, and CCNA2.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:CM-Dil dye-labeled HEL cells into zebrafish embryos at 48 h post-fertilizations[1]
-
Dosage:25, 50, 100 nM
-
Administration:1, 3, 5 days
-
Result:Showed no significant morphological abnormalities (morphology, survival, body length, and heart rate) at any examined time points (1, 3, 5 days) compared to the control group.
Did not induce significant in vivo toxicity in zebrafish embryos.Reduced HEL cell proliferation and migration.
Inhibited the proliferation of HEL cells in the zebrafish xenograft tumor model.
化学情報
-
CAS 番号 2834742-70-8
-
分子量 559.65
-
分子式 C33H37NO7
-
SMILES
O=C(CN1CCCCC1)O[C@@H]2C[C@@H](C3=CC=CC=C3)[C@@]4(C5=CC=C(OC)C=C5)[C@]2(O)C6=C(OC)C=C(OC)C=C6O4
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
A2073 関連分類
HY-174321 関連分類
Powered by Bioz